HUMAN EMBRYONIC STEM CELLS MARKET ANALYSIS

Human Embryonic Stem Cells MarketSize and Trends

The global human embryonic stem cells market was valued at US$ 1,058.9 Mn in 2021 and is forecast to reach a value of US$ 1,955.3 Mn by 2028 at a CAGR of 9.2% between 2022 and 2028. The global human embryonic stem cells market is experiencing strong growth due to the increase in focus on the development of stem cell therapies across the globe. Moreover, rise in prevalence of cardiac & malignant diseases and increase in demand for regenerative medicines across the globe is expected to boost growth of the market. However, high cost of the procedure and stringent regulatory guidelines and ethical issues are major factors expected to hamper the growth of the human embryonic stem cells market.

Figure 1. Global Human Embryonic Stem Cells Market Share (%), by Region, 2021

Global Human Embryonic Stem Cells Market Trends:

Different types of stem cells are used for therapeutic purposes. With several applications in the clinical stage for various diseases, these cells are being widely explored by a large number of pharmaceutical and biopharmaceutical companies worldwide. Stem cell biology research will show better growth due to the rise in incidence of cardiovascular and malignant diseases such as cancer, cardiac disease, diabetes, and others, and this trend is expected to continue over the forecast period, driving the growth of the market.

With the success in human embryonic stem cells and technological advancements in the field of stem cell, the number of clinical trials performed is also increasing across the globe. The AI (artificial intelligence) techniques are useful for optimizing the clinical trials of new/innovative embryonic stem cells and predictive models. Researchers worldwide are using AI to evaluate stem cell-based therapies for cardiovascular diseases, eye related diseases, and immune system related diseases, and this trend is expected to continue during the forecast period.